The expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor is correlated to angiogenesis in breast cancer

Pathology International

Volumn 48, Issue 11, 1998, Pages 850-856

  Yonenaga, Fumiyo ^a   Takasaki, Takashi ^a   Ohi, Yasuyo ^a   Sagara, Yoshiatu ^a   Akiba, Suminori ^a   Yoshinaka, Heiji ^a   Aikou, Takashi ^a   Miyadera, Kazutaka ^a,b   Akiyama, Shinichi ^a   Yoshida, Hiroki ^a,c  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b TAIHO PHARMACEUTICAL CO LTD   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Breast cancer; c erbB 2; Thymidine phosphorylase

Indexed keywords

ESTROGEN RECEPTOR; ONCOPROTEIN; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; PROGESTERONE RECEPTOR; PROTEIN P53; THYMIDINE PHOSPHORYLASE;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BREAST CANCER; FEMALE; HISTOPATHOLOGY; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

EID: 14444267310     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1998.tb03851.x     Document Type: Article

References (33)

1. Furukawa T, Yoshimura A, Sumizawa T et al. Angiogenic factor. Nature 1992; 356: 668.
2. Sumizawa T, Furukawa T, Haraguchi M et al. Thymidine phosphorylase activity associated with platelet-derived endothelial cell growth factor. J. Biochem. 1993; 114: 9-14.
3. Haraguchi M, Miyadera K, Uemura K et al. Angiogenic activity of enzymes. Nature 1994; 368: 198.
4. Miyadera K, Sumizawa T, Haraguchi M et al. Role of thymidine phosphorylase activity in the angiogenic effect of platelet-derived endothelial cell growth factor/thymidine phosphorylase. Cancer Res. 1995; 55: 1687-1690.
5. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma. N. Engl. J. Med. 1991; 324: 1-8.
6. Weidner N, Folkman J, Pozza F, Bevilacqua P, Aired EN, Moore DH. Tumor angiogenesis: A new significant and independent prognostic indicator in early stage breast carcinoma. J. Natl Cancer Inst. 1992; 84: 1875-1887.
7. Horak ER, Leek R, Klenk N et al. Angiogenesis assessed by platelet-derived cell adhesion molecular antibodies: An indicator of node metastases and survival in breast cancer. Lancet 1992; 340: 1120-1124.
8. Weidner N, Carroll PR, Flax J, Blumenfeid W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am. J. Pathol. 1993; 143: 401-409.
9. Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA. Relation of neovascularization to metastasis of non-small cell lung cancer. Lancet 1992; 340: 145-146.
10. Yamazaki K, Abe S, Takekawa H, Sudou N, Watanabe N, Ogura S. Tumor angiogenesis in human lung adenocarcinoma. Cancer 1995; 74: 2245-2250.
11. Srivastava A, Laider P, Davies RP, Horgan K, Hughes LE. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma: A quantitative histologic study. Am. J. Pathol. 1988; 133: 419-423.
12. Bicknell R, Harris AL. Novel growth regulatory factors and tumour angiogenesis. Eur. J. Cancer 1991; 27: 781-785.
13. Reynolds K, Farzaneh F, Collins WP et al. Correlation of ovarian malignancy with expression of platelet-derived endothelial cell growth factor. J. Natl Cancer Inst. 1994; 86: 1234-1238.
14. Kono A, Hara Y, Sugata S, Matsushima Y, Ueda T. Substrate specificity of a thymidine phosphorylase in human liver tumor. Chem. Pharm. Bull. 1984; 32: 1919-1921.
15. Yoshimura A, Kuwazuru Y, Furukawa T, Yoshida H, Yamada K, Akiyama S. Purification and tissue distribution of human thymidine phosphorylase: High expression in lymphocytes, reticulocytes and tumors. Biochim. Biophys. Acta 1990; 1034: 107-113.
16. Vertomgen F, Fondu P, Van Den Heule B, Cauchie C, Mandelbaum IM. Thymidine kinase and thymidine phosphorylase activities in various types of leukemia and lymphoma. Tumour Biol. 1984; 5: 303-311.
17. Zimmerman M, Seidenberg J. Deoxyribosyl transfer. I: Thymidine p[hosphorylase and nucleoside deoxyribosyl transferase in normal and malignant tissues. J. Biol. Chem. 1964; 239: 2618-2621.
18. Takebayashi Y, Yamada K, Maruyama I, Fujii R, Akiyama S, Aikou T. The expression of thymidine phosphorylase and thrombomodulin in colorectal carcinoma. Cancer Lett. 1995; 92: 1-7.
19. Takebayashi Y, Miyadera K, Akiyama S et al. Expression of thymidine phosphorylase in human gastric carcinoma. Jpn. J. Cancer Res. 1996; 87: 288-295.
20. Moghaddam A, Bicknell R. Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity. Biochemistry 1992; 31: 12 141-12 146.
21. Morris PB, Ellis MN, Swain JL. Angiogenic potency of nucleotide metabolites' potential role in ischemia-induced vascular growth. J. Mol. Cell. Cardiol. 1989; 21: 351-358.
22. Zimmerman M, Seidenberg J. Deoxyribosyl transfer. J. Biol. Chem. 1964; 230: 2618-2621.
23. Pauly JL, Schuller MG, Zelcer AA, Kris TA, Gore SS. Identification and comparative analysis of thymidine phosphorylase in the plasma of healthy subjects and cancer patients: Brief communication. J. Natl Cancer Inst. 1977; 58: 1587-1590.
24. Pauly JL, Paolini NS, Ebarb RL, Germain MJ. Elevated thymidine phosphorylase activity in the plasma and fluids of tumor-bearing animals (40034). Exp. Biol. Med. 1978; 157: 262-267.
25. Fox SB, Westwood M, Moghaddam A et al. The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. Br. J. Cancer 1996; 73: 275-280.
26. Toi M, Hoshina S, Taniguchi T, Yamamoto Y, Ishitsuka H, Tominaga T. Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer. Int. J. Cancer 1995; 64: 79-82.
27. Battegay EJ. Angiogenesis: Mechanistic insights, neovascular diseases and therapeutic prospects. J. Mol. Med. 1995; 73: 333-346.
28. Relf M, LeJeune S, Scott PAE et al. Expression of angiogenic factors, vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor β-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res. 1997; 57: 963-969.
29. Costello P, McCann A, Carney DN, Dervan PA. Prognostic significance of microvessel density in lymph node negative breast carcinoma. Hum. Pathol. 1995; 26: 1181-1184.
30. Giatromanolaki A, Koukourakis MI, O'Byrne K et al. Non-small cell lung cancer: c-erbB-2 overexpression correlates with low angiogenesis and poor prognosis. Anticancer Res. 1996; 16: 3819-3826.
31. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359: 843-845.
32. Ho CK, Ou BR, Hsu ML, Su SN, Yung CH, Wang SY. Induction of thymidine kinase activity and clonal growth of certain leukemic cell lines by a granulocyte-derived factor. Blood 1990; 75: 2438-2444.
33. Eda H, Fujimoto K, Watanabe S et al. Cytokines induce thymidine phosphorylase expression in tumor cell and make them more susceptible to 5′-deoxy-5-fluorouridine. Cancer Chemother. Phamacol. 1993; 32: 333-338.